In 2020, the World Health Organization set out its Global Strategy for Cervical Cancer Elimination. While countries are making progress towards the WHO 90-70-90 targets for vaccination, screening, and treatment, there is still work to be done to achieve this goal. Now more than ever, partnerships between diverse stakeholders at the local, regional, and global level are important to help underscore the sense of urgency and accelerate actions toward achieving cervical cancer elimination. 

Merck is a 2023 Concordia Annual Summit Lead Programming Sponsor.